Integer Holdings ( (ITGR) ) has released its Q4 earnings. Here is a breakdown of the information Integer Holdings presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Integer Holdings Corporation, a leading contract development and manufacturing organization in the medical device sector, is known for its diverse product offerings in cardiac and vascular markets. The company recently reported strong financial results for the fourth quarter and full year 2024, showcasing significant growth in sales and profits. In the fourth quarter of 2024, Integer reported an 11% increase in sales, reaching $449 million. The GAAP income from continuing operations grew by 23%, while adjusted net income rose by 6%. For the full year, sales increased by 10% to $1.717 billion, and GAAP income from continuing operations surged by 36%. The company also made strategic acquisitions, including Precision Coating and VSi Parylene, to enhance its capabilities and market offerings. Looking ahead, Integer Holdings anticipates continued growth with an expected 8% to 10% increase in sales in 2025, along with expanding profit margins, as it continues to execute its strategic initiatives.
